1887

n Cardiovascular Journal of South Africa - Lipitor stops progression of plaque build-up in arteries : drug trends in cardiology

USD

 

Abstract

Extracted from text ... Lipitor stops progression of plaque build-up in arteries Patients taking Pfizer Inc's cholesterollowering medicine Lipitor (atorvastatin calcium) experienced a significant reduction in the progression of atherosclerosis, or hardening of the arteries, compared to patients who received Prava (pravastatin), according to new data presented at the 2003 American Heart Association annual meeting. The Reversing Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) study followed 502 patients who were diagnosed with coronary heart disease and required cardiac catheterisation, or angiograms. Patients in the 18-month study had at least one arterial vessel with 20% or more constriction due to plaque build-up. This headto- head study compared ..

Loading

Article metrics loading...

/content/cardio/15/2/EJC23889
2004-03-01
2016-12-07
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error